Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
43.99 USD
0.66%
Market Closed
Updated:
May 4, 2024
Bristol-Myers Squibb Co
Total Other Income
|
Bristol-Myers Squibb Co
Total Other Income Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Other Income
-$149m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-54%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Other Income
-$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Other Income
$606m
|
CAGR 3-Years
10%
|
CAGR 5-Years
19%
|
CAGR 10-Years
8%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Other Income
$456.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
3%
|
CAGR 10-Years
20%
|
See Also
What is Bristol-Myers Squibb Co's Total Other Income?
Total Other Income
-149m
USD
-149m
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Total Other Income amounts to -149m USD.
What is Bristol-Myers Squibb Co's Total Other Income growth rate?
Total Other Income CAGR 10Y
-54%
-54%
Over the last year, the Total Other Income growth was 61%.
You don't have any saved screeners yet
